Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

6.30
-0.3100-4.69%
Post-market: 6.300.00000.00%19:22 EDT
Volume:99.19K
Turnover:631.12K
Market Cap:31.41M
PE:-0.42
High:6.60
Open:6.60
Low:6.22
Close:6.61
52wk High:70.75
52wk Low:6.22
Shares:4.99M
Float Shares:3.75M
Volume Ratio:1.27
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.0059
EPS(LYR):-14.1162
ROE:-505.14%
ROA:-30.90%
PB:-1.02
PE(LYR):-0.45

Loading ...

Mersana Therapeutics Inc expected to post a loss of $3.93 a share - Earnings Preview

Reuters
·
Aug 08

Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025

GlobeNewswire
·
Aug 06

Mersana Therapeutics trading halted, news pending

TIPRANKS
·
Jul 26

Mersana Therapeutics Announces 1-for-25 Reverse Stock Split Effective July 25, 2025

Reuters
·
Jul 24

Mersana Therapeutics Inc - Stockholders to Receive Cash in Lieu of Fractional Shares

THOMSON REUTERS
·
Jul 24

Mersana Therapeutics Inc. Completes Full Debt Repayment of $17.9 Million to Oxford Finance LLC

Reuters
·
Jul 04

Mersana Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 14

Mersana Therapeutics (MRSN) Gets a Buy from Truist Financial

TIPRANKS
·
Jun 03

Mersana Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire
·
May 20

Mersana Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Mersana Therapeutics Reports Increased Net Loss of $24.1 Million and EPS of $0.19 for Q1 2025

Reuters
·
May 15

Mersana Therapeutics Q1 EPS $(0.19), Inline, Sales $2.75M Miss $5.84M Estimate

Benzinga
·
May 15

BRIEF-Mersana Therapeutics Q1 EPS USD -0.19

Reuters
·
May 15

Mersana Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 13

Wedbush Cuts Price Target on Mersana Therapeutics to $3 From $4, Maintains Outperform Rating

MT Newswires Live
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Marriott, IQVIA

Reuters
·
May 06

BUZZ-Mersana Therapeutics announces restructuring plans; shares fall

Reuters
·
May 06

Mersana Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 05

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting

GlobeNewswire
·
Apr 23

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 05